Related Experiment Video
Updated: Jun 6, 2025

05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
3.6K
A Heat Sensitivity Scale for People with Parkinson's Disease
Andrew P Hunt1, Aline Souza Pagnussat2,3, Alexander Lehn1,4
1School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
Movement Disorders Clinical Practice
|November 27, 2024
Summary
People with Parkinson's disease (PD) often struggle with heat sensitivity. A new scale helps assess the impact of heat on daily activities, symptoms, and illness in PD patients.
Area of Science:
- Neurology
- Clinical Assessment
- Patient-Reported Outcomes
Background:
- Parkinson's disease (PD) patients frequently report exacerbated symptoms and functional limitations due to heat sensitivity.
- Managing heat sensitivity is crucial for maintaining daily activities and quality of life in individuals with PD.
Purpose of the Study:
- To develop and validate a reliable scale for measuring heat sensitivity in people with Parkinson's disease.
Main Methods:
- Literature and online forum searches identified 41 initial items, refined to 36 after expert review (Content Validity Index=0.89).
- An online survey collected responses from 247 individuals with PD.
- Exploratory factor analysis identified four key factors: daily activities, sweating/exercise, heat illness, and symptoms/medications, using 29 items.
Main Results:
- The final 29-item scale demonstrated a robust four-factor structure with excellent model fit statistics.
- High internal consistency was observed for each factor (Cronbach's α ≥0.89).
- Higher scale scores correlated significantly with self-reported heat sensitivity and poorer health status.
Conclusions:
- The developed scale provides a validated tool for assessing heat sensitivity in Parkinson's disease.
- This scale can aid healthcare professionals and patients in evaluating the severity and impact of heat sensitivity, informing management strategies.
Related Concept Videos
Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K

